Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccines.

zur Megede J, Otten GR, Doe B, Liu H, Leung L, Ulmer JB, Donnelly JJ, Barnett SW.

J Virol. 2003 Jun;77(11):6197-207.

2.
3.

Cross-clade T lymphocyte-mediated immunity to HIV type 1: implications for vaccine design and immunodetection assays.

Keating SM, Bollinger RC, Quinn TC, Jackson JB, Carruth LM.

AIDS Res Hum Retroviruses. 2002 Sep 20;18(14):1067-79.

PMID:
12396458
4.

Strategies for an HIV vaccine.

Letvin NL.

J Clin Invest. 2002 Jul;110(1):15-20. Review. No abstract available.

5.

Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization.

Chakrabarti BK, Kong WP, Wu BY, Yang ZY, Friborg J, Ling X, King SR, Montefiori DC, Nabel GJ.

J Virol. 2002 Jun;76(11):5357-68.

6.

Issues for improving multiplasmid DNA vaccines for HIV-1.

Muthumani K, Kudchodkar S, Zhang D, Bagarazzi ML, Kim JJ, Boyer JD, Ayyavoo V, Pavlakis GN, Weiner DB.

Vaccine. 2002 May 6;20(15):1999-2003. Review.

PMID:
11983262
7.

Muscle specific versus ubiquitous expression of Gag based HIV-1 DNA vaccines: a comparative analysis.

Bojak A, Hammer D, Wolf H, Wagner R.

Vaccine. 2002 May 6;20(15):1975-9.

PMID:
11983257
8.

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes.

Barouch DH, Kunstman J, Kuroda MJ, Schmitz JE, Santra S, Peyerl FW, Krivulka GR, Beaudry K, Lifton MA, Gorgone DA, Montefiori DC, Lewis MG, Wolinsky SM, Letvin NL.

Nature. 2002 Jan 17;415(6869):335-9.

PMID:
11797012
9.

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.

Shiver JW, Fu TM, Chen L, Casimiro DR, Davies ME, Evans RK, Zhang ZQ, Simon AJ, Trigona WL, Dubey SA, Huang L, Harris VA, Long RS, Liang X, Handt L, Schleif WA, Zhu L, Freed DC, Persaud NV, Guan L, Punt KS, Tang A, Chen M, Wilson KA, Collins KB, Heidecker GJ, Fernandez VR, Perry HC, Joyce JG, Grimm KM, Cook JC, Keller PM, Kresock DS, Mach H, Troutman RD, Isopi LA, Williams DM, Xu Z, Bohannon KE, Volkin DB, Montefiori DC, Miura A, Krivulka GR, Lifton MA, Kuroda MJ, Schmitz JE, Letvin NL, Caulfield MJ, Bett AJ, Youil R, Kaslow DC, Emini EA.

Nature. 2002 Jan 17;415(6869):331-5.

PMID:
11797011
10.

Vaccine protection against functional CTL abnormalities in simian human immunodeficiency virus-infected rhesus monkeys.

McKay PF, Schmitz JE, Barouch DH, Kuroda MJ, Lifton MA, Nickerson CE, Gorgone DA, Letvin NL.

J Immunol. 2002 Jan 1;168(1):332-7.

11.
12.

Frequency and function of HIV-specific CD8(+) T cells.

Migueles SA, Connors M.

Immunol Lett. 2001 Nov 1;79(1-2):141-50.

PMID:
11595301
13.

Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design.

Novitsky V, Rybak N, McLane MF, Gilbert P, Chigwedere P, Klein I, Gaolekwe S, Chang SY, Peter T, Thior I, Ndung'u T, Vannberg F, Foley BT, Marlink R, Lee TH, Essex M.

J Virol. 2001 Oct;75(19):9210-28.

14.

Vaccines for the prevention of HIV-1 disease.

Mascola JR, Nabel GJ.

Curr Opin Immunol. 2001 Aug;13(4):489-95. Review.

PMID:
11498307
15.

Use of overlapping peptide mixtures as antigens for cytokine flow cytometry.

Maecker HT, Dunn HS, Suni MA, Khatamzas E, Pitcher CJ, Bunde T, Persaud N, Trigona W, Fu TM, Sinclair E, Bredt BM, McCune JM, Maino VC, Kern F, Picker LJ.

J Immunol Methods. 2001 Sep 1;255(1-2):27-40.

PMID:
11470284
16.

Protection from immunodeficiency virus challenges in rhesus macaques by multicomponent DNA immunization.

Kim JJ, Yang JS, Nottingham LK, Lee DJ, Lee M, Manson KH, Wyand MS, Boyer JD, Ugen KE, Weiner DB.

Virology. 2001 Jul 5;285(2):204-17.

17.

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

Amara RR, Villinger F, Altman JD, Lydy SL, O'Neil SP, Staprans SI, Montefiori DC, Xu Y, Herndon JG, Wyatt LS, Candido MA, Kozyr NL, Earl PL, Smith JM, Ma HL, Grimm BD, Hulsey ML, Miller J, McClure HM, McNicholl JM, Moss B, Robinson HL.

Science. 2001 Apr 6;292(5514):69-74.

18.

Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53.

Dorrell L, Willcox BE, Jones EY, Gillespie G, Njai H, Sabally S, Jaye A, DeGleria K, Rostron T, Lepin E, McMichael A, Whittle H, Rowland-Jones S.

Eur J Immunol. 2001 Jun;31(6):1747-56.

19.

Interactions of single and combined human immunodeficiency virus type 1 (HIV-1) DNA vaccines.

Kjerrström A, Hinkula J, Engström G, Ovod V, Krohn K, Benthin R, Wahren B.

Virology. 2001 May 25;284(1):46-61.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk